Vitamin B6 Competition in the Tumor Microenvironment Hampers Antitumor Functions of NK Cells

Chunbo He(University of Oklahoma Health Sciences Center), Dezhen Wang(University of Nebraska Medical Center), Surendra K. Shukla(University of Oklahoma Health Sciences Center), Tuo Hu(University of Nebraska Medical Center), Ravi Thakur(University of Oklahoma Health Sciences Center), Xiao Fu(Nanjing Drum Tower Hospital), Ryan J. King(University of Nebraska Medical Center), Sai Sundeep Kollala(University of Nebraska Medical Center), Kuldeep S. Attri(University of Nebraska Medical Center), Divya Murthy(University of Nebraska Medical Center), Nina V. Chaika(University of Nebraska Medical Center), Yuki Fujii(University of Oklahoma Health Sciences Center), Daisy González(University of Nebraska Medical Center), Camila G. Pacheco(University of Nebraska Medical Center), Yudong Qiu(Nanjing Drum Tower Hospital), Pankaj K. Singh(University of Oklahoma Health Sciences Center), Jason W. Locasale(Duke University), Kamiya Mehla(University of Oklahoma Health Sciences Center)
Cancer Discovery
November 6, 2023
Cited by 56Open Access
Full Text

Abstract

Nutritional factors play crucial roles in immune responses. The tumor-caused nutritional deficiencies are known to affect antitumor immunity. Here, we demonstrate that pancreatic ductal adenocarcinoma (PDAC) cells can suppress NK-cell cytotoxicity by restricting the accessibility of vitamin B6 (VB6). PDAC cells actively consume VB6 to support one-carbon metabolism, and thus tumor cell growth, causing VB6 deprivation in the tumor microenvironment. In comparison, NK cells require VB6 for intracellular glycogen breakdown, which serves as a critical energy source for NK-cell activation. VB6 supplementation in combination with one-carbon metabolism blockage effectively diminishes tumor burden in vivo. Our results expand the understanding of the critical role of micronutrients in regulating cancer progression and antitumor immunity, and open new avenues for developing novel therapeutic strategies against PDAC. SIGNIFICANCE: The nutrient competition among the different tumor microenvironment components drives tumor growth, immune tolerance, and therapeutic resistance. PDAC cells demand a high amount of VB6, thus competitively causing NK-cell dysfunction. Supplying VB6 with blocking VB6-dependent one-carbon metabolism amplifies the NK-cell antitumor immunity and inhibits tumor growth in PDAC models. This article is featured in Selected Articles from This Issue, p. 5.


Related Papers